Toxicities associated with CAR T cell therapy can be numerous including (1) cytokine release syndrome (CRS) which is characterized by a fever induced by high serum levels of IL-6 and IFNγ (2) respiratory distress and (3) neurological symptoms (23–26). This evidence concerns the gene IL6 and congenital rubella syndrome.